Navigation Links
Prostate Cancer Translational Research in Europe meeting: Search for biomarkers continues
Date:6/22/2009

nother consortium, searches for genetic variants that do associate with aggressive cancer forms.

She also noted that the information on PSA genetics may improve utility in screening. Rafnar also pointed out that although "...much work remains. finding causative variants at known loci define functions."

The lecture by Prof. Freddie Hamdy (Oxford, UK), 'What is the best practice in bio-banking?' focussed on the dilemmas in prostate cancer (how to identify the population at risk, how to prevent overtreatment and treatment failure). "We can treat, we can cure, but who should we treat and cure?", he said. Collection and cohorts of prostate cancer samples are important in order to look for new biomarkers. But the search for prognostic markers needs a multi-targeted approach. "The focus should be on the benefit to the patient; it should result in e.g. a reduction in mortality or of side effects", says Hamdy.

Dr Schenk-Braat (Rotterdam, NL) says: "The incidence of prostate cancer will increase and PSA is not a sensitive enough tool to identify men at risk". The P-Mark project evaluates promising biomarkers and has selected 3: osteoprotegerin (a bone turnover protein discovered by the group of Prof Hamdy), PCA3 (Jacques Schalkens (Nijmegen, NL) group) and multikallikreins (project of Profs Lilja (New York, US) and Petterson). An across marker validation study is ongoing. "We can name the European prostate biobank, increased support of the validation of biomakers and the prostate risk indicator as a few results from the P-Mark project", says Schenk-Braat.

In another update lecture, Dr. O. Kallioniemi (Helsinki, Finland) discussed the integration of high-throughput technologies to identify drug targets and new therapeutic options for prostate cancer. Amongst his conclusions are:

  • Majority of anti-cancer drugs are equally effective in cancer and control cells.
  • TSA, thiram, disalfiram and monensin (are) identified as cancer s
    '/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
European Association of Urology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Green tea may affect prostate cancer progression
2. Gene activity reveals dynamic stroma microenvironment in prostate cancer
3. 3-D research model tackles prostate cancer spread
4. Agent Orange exposure increases veterans risk of aggressive recurrence of prostate cancer
5. New drug shows promise in treating drug-resistant prostate cancer
6. New medications show promise in treating drug-resistant prostate cancer
7. Freezing prostate cancer does a mans body good
8. Dana-Farber oncologists present at ASCO GU -- predict prostate cancer survival using Source MDx test
9. New lab evidence suggests preventive effect of herbal supplement in prostate cancer
10. Men with wives, significant others more likely to be screened for prostate cancer
11. Prostate cancer spurs new nerves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... N.C. -- When we want to listen carefully to ... The second thing we do is stop moving altogether. ... sounds generated by our own movements. , This interplay ... in the brain. Indeed, indirect evidence has long suggested ... influences the auditory cortex, which gives rise to our ...
(Date:8/27/2014)... CHICAGO , Aug. 27, 2014 /PRNewswire-iReach/ -- The ... hosting the 36 th Annual International Conference (EMBC,14), ... and Towers in Chicago, Illinois , ... than 2,500 global leaders, students, and industry professionals in ... Logo - http://photos.prnewswire.com/prnh/20140827/140333 ...
(Date:8/27/2014)... Ebola is a rare, but deadly disease that exists ... One of the most lethal strains is the Sudan ... Africa, SUDV has caused widespread illness, even as recently ... journal ACS Chemical Biology , researchers now report ... infected with SUDV. , John Dye, Sachdev Sidhu, Jonathan ...
Breaking Biology News(10 mins):Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 3Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2
... at the University of British Columbia have been able ... much touted antioxidant benefits, tracing valuable compounds to the ... Prof. David Kitts found that the prevailing antioxidants present ... green beans being browned under high temperatures. ...
... PORTLAND, Ore. February 1, 2011. Fact: The ... temperature of the nest: warm nests produce females, cooler nests, ... for about 220 million years, scientists now report that almost ... working to understand how global warming may affect turtle reproduction. ...
... dementia is caused by a breakdown of nerve cells ... (fronto-temporal lobe), which leads to, among other symptoms, a ... forms of frontotemporal dementia is a genetically determined reduction ... Anja Capell and Prof. Christian Haass have now shown ...
Cached Biology News:Roasting coffee beans a dark brown produces valued antioxidants: UBC food scientists 2Turtle populations affected by climate, habitat loss and overexploitation 2Malaria medication may help against 1 type of frontotemporal dementia 2
(Date:8/27/2014)... , Aug. 27, 2014 Tris Pharma, ... delivery technologies, today announced that it has been selected ... & Industry Association,s 2014 Awards for Excellence ... by an independent panel of judges from SCORE (Counselors ... Award winners will be honored at a gala event ...
(Date:8/27/2014)... 27, 2014 After the boom of ... the next beverage craze is going to be the ... formulators can use Stress Relief energy pattern which can ... making of a beverage, including minerals, herbs and liquids. ... channeling that power into rapid recovery and helping to ...
(Date:8/27/2014)... NJ (PRWEB) August 27, 2014 WriteResult, ... services – has once again shown superiority when it ... sponsor by completing the ePRO portion of their most ... The Japan-based pharma chose WriteResult’s digital writing platform ... trials – the first to complete drew data from ...
(Date:8/26/2014)... , Aug. 26, 2014  NeuroSigma, Inc., a ... established to develop bioelectronic technologies, today announced that it ... the U.S. Securities and Exchange Commission relating to a ... number of shares to be offered and the price ... determined. Jefferies LLC will act as the ...
Breaking Biology Technology:Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4A Perfect Record: WriteResult Maintains a 100% On-Time ePRO Record with Latest Irritable Bowel (IBS) Study Data Lock 2
... Human Genome Sciences, Inc. (Nasdaq: HGSI ... ) has initiated a Phase 3 clinical trial program ... Syncria (R) (albiglutide) in the long-term treatment of type ... receive a $9 million milestone payment in the first ...
... Inc., a technology leader in developing novel chip-on-catheter digital ... new 510(k) clearance for its Third Eye(R) Retroscope(R) (Third ... and pre-cancerous polyps in the colon. This is ... FDA to enhance polyp detection when used in conjunction ...
... www.WhatWillYourPlanBe.com offers post college-aged women expert guidance in ... 17 Many young women enter the "real ... plan, particularly when it comes to their careers, ... that the unexpected often happens -- a looming ...
Cached Biology Technology:Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 2Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 3Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 4Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon 2Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon 3Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon 4Helping Young Women Succeed in Today's Unpredictable World 2Helping Young Women Succeed in Today's Unpredictable World 3Helping Young Women Succeed in Today's Unpredictable World 4
MAb to Catenin beta, N-terminal (exon 2) Catenin, beta, N-terminal (exon 2)...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
Anti-Src-Like Adaptor Protein-2 AVOID FREEZE/THAW CYCLES. Recognizes the ~25 and ~28 kDa forms SLAP-2....
... media for spontaneous ligand immobilization can be coupled ... antigen, or receptor to create an affinity matrix ... couple ligands via primary amines. Affi-Gel 10 gel ... 6.5 to 11; Affi-Gel 15 gel couples acidic ...
Biology Products: